使AAVFRα

Yuanjie Zhang1,2,3,4, Yingying Shi1,2,3,4, Xueying Zhou1,2,3,4

  • 1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Molecular pharmaceutics
|December 3, 2025
PubMed
概括

工程设计的腺相关病毒 (AAV) 载体使用叶酸受体α (FRα) 更有效地向癌细胞. 这种精确的基因疗法方法提高了输送效率,并减少了用于改善癌症治疗的非目标效应.